Catherine A. McCarty

Catherine A. McCarty

Auto-generated profile, based on publicly available information

Catherine A. McCarty

Department of Family Medicine and Biobehavioral Health, Medical School, University of Minnesota, Duluth, MN 55812, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
DFDavid S Friedman
David S Friedman
BOBenita J O'Colmain
Benita J O'Colmain
BMBeatriz Muñoz
Beatriz Muñoz
STSandra C Tomany
Sandra C Tomany
CMCathy McCarty
Cathy McCarty
EGEye Diseases Prevalence Research Group
Eye Diseases Prevalence Research Group
Research from JAMA Ophthalmology — Prevalence of Age-Related Macular Degeneration in the United States

27 May 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DHDavid J Hunter
David J Hunter
PKPeter Kraft
Peter Kraft
KJKevin B Jacobs
Kevin B Jacobs
DCDavid G Cox
David G Cox
MYMeredith Yeager
Meredith Yeager
SCStephen J Chanock
Stephen J Chanock

1 December 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JDJoshua C Denny
Joshua C Denny
LBLisa Bastarache
Lisa Bastarache
MRMarylyn D Ritchie
Marylyn D Ritchie
RCRobert J Carroll
Robert J Carroll
RZRaquel Zink
Raquel Zink
DRDan M Roden
Dan M Roden

1 October 2013 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
OGOmri Gottesman
Omri Gottesman
HKHelena Kuivaniemi
Helena Kuivaniemi
GTGerard Tromp
Gerard Tromp
WFW. Andrew Faucett
W. Andrew Faucett
RLRongling Li
Rongling Li
MWMarc Williams
Marc Williams
The Electronic Medical Records and Genomics Network is a National Human Genome Research Institute–funded consortium engaged in the development of methods and best practices for using the electronic medical record as a tool for genomic research. Now in its sixth year and second funding cycle, and comprising nine research groups and a coordinating center, the network has played a major role in validating the concept that clinical data derived from electronic medical records can be used successfully for genomic research. Current work is advancing knowledge in multiple disciplines at the intersection of genomics and health-care informatics, particularly for electronic phenotyping, genome-wide association studies, genomic medicine implementation, and the ethical and regulatory issues associated with genomics research and returning results to study participants. Here, we describe the evolution, accomplishments, opportunities, and challenges of the network from its inception as a five-group consortium focused on genotype–phenotype associations for genomic discovery to its current form as a nine-group consortium pivoting toward the implementation of genomic medicine. Genet Med 15 10, 761–771.

26 January 2011 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
TTthe eMERGE Team
the eMERGE Team
CMCatherine A McCarty
Catherine A McCarty
RCRex L Chisholm
Rex L Chisholm
CCChristopher G Chute
Christopher G Chute
Iftikhar KulloIftikhar Kullo
Iftikhar Kullo
WWWendy A Wolf
Wendy A Wolf
The eMERGE (electronic MEdical Records and GEnomics) Network is an NHGRI-supported consortium of five institutions to explore the utility of DNA repositories coupled to Electronic Medical Record (EMR) systems for advancing discovery in genome science. eMERGE also includes a special emphasis on the ethical, legal and social issues related to these endeavors. The five sites are supported by an Administrative Coordinating Center. Setting of network goals is initiated by working groups: (1) Genomics, (2) Informatics, and (3) Consent & Community Consultation, which also includes active participation by investigators outside the eMERGE funded sites, and (4) Return of Results Oversight Committee. The Steering Committee, comprised of site PIs and representatives and NHGRI staff, meet three times per year, once per year with the External Scientific Panel. The primary site-specific phenotypes for which samples have undergone genome-wide association study (GWAS) genotyping are cataract and HDL, dementia, electrocardiographic QRS duration, peripheral arterial disease, and type 2 diabetes. A GWAS is also being undertaken for resistant hypertension in ≈2,000 additional samples identified across the network sites, to be added to data available for samples already genotyped. Funded by ARRA supplements, secondary phenotypes have been added at all sites to leverage the genotyping data, and hypothyroidism is being analyzed as a cross-network phenotype. Results are being posted in dbGaP. Other key eMERGE activities include evaluation of the issues associated with cross-site deployment of common algorithms to identify cases and controls in EMRs, data privacy of genomic and clinically-derived data, developing approaches for large-scale meta-analysis of GWAS data across five sites, and a community consultation and consent initiative at each site. Plans are underway to expand the network in diversity of populations and incorporation of GWAS findings into clinical care. By combining advanced clinical informatics, genome science, and community consultation, eMERGE represents a first step in the development of data-driven approaches to incorporate genomic information into routine healthcare delivery.

1 June 1998 in Ophthalmology
Verified
Journal Article
Closed access
CMC A McCarty
C A McCarty
ABA K Bansal
A K Bansal
PLP M Livingston
P M Livingston
YSY L Stanislavsky
Y L Stanislavsky
HTH R Taylor
H R Taylor